Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The deal grants Genentech exclusive global rights to develop and commercialise t...
The therapy aims to treat Type I allergic reactions, including anaphylaxis, in p...
Sun Pharma Advanced Research Company (SPARC) announced that the United States ...
Lupin announced the launch of Dasatinib tablets, 20 mg, 50 mg, 70 mg, 80 mg, 10...
India's Foremost Pharma & Biotech Magazine ~ Friendshoring: Pharma's Next Suppl...
AstraZeneca Pharma India, a global, science-led biopharmaceutical company, anno...
The initiative aims to speed up the development of platform-based genetic therap...
The CHMP recommends the use of niraparib and abiraterone acetate with prednisone...
Lupin announced a strategic collaboration with TB Alliance, a nonprofit drug de...
The Uttar Pradesh Food Safety and Drug Administration (FSDA) and Invest UP will...
By 2030, what will truly differentiate winning OTC players in India from the re...
PFAS testing gets complicated fast, not because the science is impossible, but ...
PFAS in water testing is unforgiving: target lists vary by matrix, action level...
PFAS has moved from a technical concern to a leadership agenda item. For food b...
The signing of the India-EU Free Trade Agreement after almost two decades of ne...
Industry stakeholders view the Union Budget 2026 as a pivotal inflection point ...